You are a helpful, respectful, and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information.
What is Denosumab is used in treatment of - and explain in detail?
Ans. is 'a' i.e., Postmenopausal osteoporosis & 'b' i.e., Osteoclastoma' Denosumab* Denosumab is a monoclonal antibody, which inhibits osteoclast differentiation and function as well as promotes their apoptosis.* Osteoclast is a cell responsible for bone resorption.* Osteoclasts express RANK receptors on its surface (RANK receptor activator for nuclear factor).* When RANK receptor combine with their ligands (RANKL) osteoclastogenesis is initiated and bone resorption occurs.* Donesumab is a monoclonal antibody against RANK ligand. It prevents the activation of the osteoclasts by these ligand.* Osteoporosis is a disease characterized by decrease in the bone mass. In osteoporosis there is increase in the osteoclast activity and there is increased expression of RANK and RANKL.* Thus denosumab is the treatment option for osteoporosis when no other drug is appropriate.* Denosumab is also the only FDA approved drug for treatment of osteoclastoma.